A combined diagnostic-therapeutic strategy to optimize management of patients with previously unrecognized heart failure in primary care

Completed

• Conditions: 10019280; Decompensatio cordis; Heart failure

• Registration Number: NL-OMON36824
• Lead Sponsor: niversitair Medisch Centrum Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 700

Inclusion Criteria

Age 65 years or over.
Shortness of breath as reason for GP contact in the previous 12 months.

Exclusion Criteria

Already established heart failure, that is a diagnosis of heart failure confirmed by the cardiologist with echocardiography.
A life expectancy shorter than 6 months.
Not being able to give informed consent.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary outcome of the diagnostic part of our combined<br /><br>diagnostic-therapeutic strategy is:<br /><br>- Prevalence of 'systolic' and 'diastolic' heart failure in elderly who<br /><br>presented to the general practitioner with shortness of breath on exertion.<br /><br><br /><br>The primary outcomes of the therapeutic part of our combined<br /><br>diagnostic-therapeutic strategy are:<br /><br>- Difference in distance walked during the 6 minutes walking test as measure<br /><br>for functionality between patients in the intervention and control group after<br /><br>6 months follow-up;<br /><br>- Difference in quality of life between patients in the two groups after 6<br /><br>months follow-up;<br /><br>- Difference in prescription of ACE-inhibitors and beta-blockers in the two<br /><br>groups after 6 months follow-up.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>- Differences in heart failure related doctor-appointments and hospitalization<br /><br>rates between the intervention and control group during 6 months follow-up;<br /><br>- Cost-effectiveness of the implemented diagnostic-therapeutic strategy.</p><br>